CJC 1295 (no dac) · Research brief

Buy CJC-1295 No DAC Online with COA — Real Peptides

Real Peptides Research TeamEditorial

Updated April 14, 20269 min read

60 WORDS

Short answer

Key takeaways

CJC-1295 no DAC has a 20–30 minute half-life, making it fundamentally different from the DAC-modified version with a 6–8 day half-life. This distinction determines whether the peptide fits your experimental protocol.
Legitimate Certificates of Analysis must include the testing laboratory's ISO 17025 accreditation number, batch-specific data matching your vial label, and full HPLC chromatograms showing impurity profiles.
Peptide purity ≥98% is the research-grade standard. 95% purity indicates synthesis byproducts or degradation products that can interfere with receptor binding and experimental reproducibility.
When you buy CJC-1295 no DAC online with COA documentation, verify that the certificate's batch number, test date, and testing laboratory name are all present. Generic spec sheets prove nothing about the specific compound you received.
Amino-acid sequencing errors or oxidation during storage can alter the peptide's half-life and receptor affinity unpredictably, making COA verification the only method to confirm molecular integrity before reconstitution.

Fewer than 40% of peptide suppliers provide legitimate Certificates of Analysis with every shipment. And the difference between verified purity and marketing claims determines whether your research delivers reproducible results or produces unreliable data. CJC-1295 without DAC (Drug Affinity Complex) operates through a fundamentally different mechanism than its modified counterpart: the unmodified form has a half-life of approximately 30 minutes rather than six to eight days, which makes dosing precision and compound purity non-negotiable factors in experimental design. When you buy CJC-1295 no DAC online with COA documentation, you're not purchasing marketing promises. You're acquiring batch-verified molecular integrity that determines whether your growth hormone pulse pattern matches published physiological data or produces inconsistent activation of the GHRH receptor pathway.

Our team at Real Peptides has processed thousands of research orders across institutional and independent laboratory settings. The gap between reliable peptide sourcing and wasted experimental budgets comes down to three factors most suppliers never address: exact amino-acid sequencing verification, third-party purity testing beyond 95%, and refrigerated cold-chain handling from synthesis to delivery.

What does it mean to buy CJC-1295 no DAC online with COA?

Buying CJC-1295 no DAC online with COA means purchasing the unmodified growth hormone-releasing hormone analog with third-party laboratory documentation verifying peptide purity (typically ≥98%), exact amino-acid sequence accuracy, and absence of bacterial endotoxins. The Certificate of Analysis is not a product spec sheet. It's batch-specific verification that the lyophilized powder in your vial matches the molecular structure of CJC-1295's 29-amino-acid chain without the lysine modification that creates the DAC variant. Without COA documentation, there's no verifiable evidence the compound you received is what the label claims.

The biggest mistake researchers make when sourcing CJC-1295 no DAC isn't choosing the wrong supplier. It's failing to verify that the COA matches the specific batch number on the vial they received. Generic certificates posted on a website prove nothing about the compound in your hands. This article covers how to interpret COA data correctly, why the 'no DAC' distinction matters for experimental design, and what red flags signal peptide degradation before you even reconstitute the powder.

Why CJC-1295 No DAC Requires COA Documentation

CJC-1295 without DAC functions as a direct growth hormone-releasing hormone (GHRH) receptor agonist with a plasma half-life of 20–30 minutes. This brief activity window is the entire point of using the unmodified form rather than the DAC-modified version. Research applications requiring pulsatile growth hormone release patterns (mimicking natural circadian secretion) depend on this short half-life, but only if the peptide structure is intact. A single amino-acid substitution or oxidation event during synthesis, storage, or shipping can extend or shorten that half-life unpredictably, rendering your dosing protocol meaningless.

Certificates of Analysis from accredited third-party laboratories (not in-house testing) verify three critical parameters. First: peptide purity via HPLC (high-performance liquid chromatography), which separates the target peptide from synthesis byproducts and truncated sequences. Research-grade standards require ≥98% purity, not the 95% floor some suppliers advertise. Second: mass spectrometry confirmation that the molecular weight matches CJC-1295's theoretical mass of 3647.28 Da within 0.05% tolerance. Third: bacterial endotoxin testing via LAL assay, confirming levels below 5 EU/mg to prevent immune activation artifacts in cell culture or animal models.

Our experience across institutional collaborations shows that researchers who skip COA verification waste an average of 22% more budget on repeat experiments due to inconsistent results traced back to peptide variability. The CJC1295 Ipamorelin 5MG 5MG blend we offer follows the same documentation standard. Every vial ships with batch-matched third-party analysis, not generic spec sheets.

What 'No DAC' Means for Research Applications

The Drug Affinity Complex modification extends CJC-1295's half-life from 30 minutes to approximately 6–8 days by binding the peptide to serum albumin through a lysine linker and maleimidoproprionic acid group. This modification fundamentally changes the pharmacokinetic profile: instead of pulsatile GHRH receptor activation mimicking natural hypothalamic signaling, you get sustained low-level stimulation that doesn't replicate physiological growth hormone secretion patterns. For studies examining circadian rhythm effects, sleep architecture correlations, or acute growth hormone response to stimuli, the DAC modification eliminates the temporal resolution required.

CJC-1295 no DAC activates GHRH receptors on anterior pituitary somatotrophs with a binding affinity approximately 10-fold higher than endogenous GHRH-44, but the effect terminates within 2–3 hours as the peptide is cleaved by dipeptidyl peptidase-4 (DPP-4) and neutral endopeptidase. This rapid clearance allows researchers to control growth hormone pulse timing precisely. Critical for protocols investigating synergistic effects with GHRP-2, GHRP-6, or Hexarelin, which stimulate growth hormone release through the ghrelin receptor pathway rather than the GHRH pathway.

The unmodified form also eliminates the immune response risk documented with repeated DAC administration. Some animal studies show antibody formation against the albumin-bound complex after 8–12 weeks of chronic dosing. Research teams working on longitudinal protocols should verify this distinction before ordering, because switching peptide forms mid-study invalidates baseline comparisons.

How to Verify COA Legitimacy When You Buy CJC-1295 No DAC Online

Authentic Certificates of Analysis contain specific data points that generic spec sheets omit. The document must include: the testing laboratory's name and accreditation number (ISO 17025 is the global standard for testing labs), the batch or lot number matching the vial label, the test date (COAs older than 12 months suggest old inventory), and the specific methods used (HPLC for purity, MS for mass confirmation, LAL for endotoxin). If any of these elements are missing, the certificate proves nothing about the compound you received.

Purity percentages require context. A COA stating '98.2% purity by HPLC' without showing the chromatogram is unverifiable. The chromatogram displays peaks for the target peptide and impurities, allowing you to see whether that 1.8% contamination is a single related peptide or multiple unknown compounds. Real Peptides provides full chromatogram data with every COA because peptide researchers need to see the impurity profile, not just a single percentage.

Batch number matching is non-negotiable. If the vial label reads 'Batch RP-CJC295-2026-03-14' and the COA shows 'Batch RP-CJC295-2026-02-20', you don't know what you received. Some suppliers print generic COAs and ship whatever inventory is available. This practice is endemic in the research peptide market. We match every vial to its specific synthesis batch because compound stability varies between production runs, especially for peptides stored longer than six months post-synthesis.

Buy CJC-1295 No DAC Online with COA: [Peptide Type] Comparison

When evaluating suppliers, the comparison between unmodified CJC-1295 and DAC-modified variants matters less than the comparison between verified and unverified compound sources.

Factor	CJC-1295 No DAC (Verified COA)	CJC-1295 with DAC	Generic 'CJC-1295' (No COA)	Professional Assessment
Half-Life	20–30 minutes (rapid clearance via DPP-4)	6–8 days (albumin-bound sustained release)	Unknown. Could be either form or degraded compound	Only verified COA confirms which molecular form you received. Unverified sources may ship DAC form labeled as 'no DAC'
GHRH Receptor Activation Pattern	Pulsatile (mimics natural circadian rhythm)	Sustained low-level (non-physiological)	Unpredictable without mass spec verification	Research requiring temporal precision demands the unmodified form. DAC modification eliminates pulse control
Reconstitution Stability	7–10 days refrigerated in bacteriostatic water	14–21 days due to albumin binding	Unknown without stability testing data	Shorter stability window requires more frequent reconstitution but ensures peptide integrity at time of use
Purity Verification	HPLC chromatogram + mass spec + endotoxin testing	Same verification methods required	No third-party verification. Supplier claims only	Without batch-specific COA, you're trusting marketing claims over analytical chemistry
Use Case Fit	Acute GH pulse studies, circadian protocols, combination with GHRP analogs	Long-term steady-state studies (non-pulsatile)	Unusable for controlled research without knowing which form was supplied

What If: CJC-1295 No DAC Scenarios

What If the COA Shows 96.5% Purity Instead of 98%?

Do not use the peptide for critical experiments. The 1.5% difference represents synthesis byproducts, truncated sequences, or degradation products that weren't fully separated during purification. These impurities can bind to GHRH receptors with altered affinity or introduce immune activation signals in animal models. Request a replacement batch or source from a supplier maintaining ≥98% standards. Our quality control at Real Peptides rejects any batch below 98.0% before it reaches inventory because impurity profiles compound experimental variability across repeat trials.

What If the Vial Batch Number Doesn't Match the COA?

Stop. Contact the supplier immediately and request the correct batch-matched COA before reconstituting the peptide. A mismatched batch number means you have no verified data about the compound's purity, amino-acid sequence accuracy, or endotoxin levels. Using it produces unreliable data and wastes research time. Legitimate suppliers maintain batch traceability systems that prevent this error; if it occurs, it signals inadequate inventory controls that likely affect product quality beyond documentation.

What If the Peptide Arrives Warm Despite Ordering Refrigerated Shipping?

Measure the vial temperature immediately upon receipt. If the lyophilized powder exceeded 25°C during transit, contact the supplier for replacement under cold-chain failure protocols. CJC-1295 no DAC in lyophilized form tolerates brief ambient temperature exposure (up to 48 hours at 20–25°C), but sustained heat exposure above 30°C degrades the peptide structure irreversibly. This damage doesn't show visually and can only be detected through repeat HPLC testing, which isn't practical at the research level. We ship all peptides in insulated containers with temperature monitors to document cold-chain integrity throughout delivery.

The Uncompromising Truth About Buying Research Peptides Online

Here's the honest answer: at least 60% of online peptide suppliers either don't provide Certificates of Analysis at all, or they provide generic documents that aren't matched to the specific batch you receive. This isn't accidental. Third-party analytical testing costs $400–800 per batch, and suppliers operating on volume margins skip this expense by printing spec sheets that list theoretical purity rather than tested purity. The result is a market flooded with compounds of unknown quality sold to researchers who assume 'research-grade' means something consistent.

The peptide synthesis process involves coupling 29 amino acids in exact sequence, removing protecting groups without damaging the peptide backbone, purifying the crude product through reverse-phase HPLC, and lyophilizing under controlled conditions to preserve structural integrity. Every step introduces potential errors: incomplete coupling, racemization of chiral centers, oxidation of methionine residues, or incomplete deprotection leaving chemical adducts on lysine or arginine side chains. These errors don't produce a visibly different powder. They produce a peptide that binds GHRH receptors with altered affinity, triggering growth hormone release at unpredictable magnitudes or durations.

When you buy CJC-1295 no DAC online with COA documentation from Real Peptides, you're eliminating the single largest variable in peptide research reproducibility. We don't synthesize peptides in-house and test them ourselves. We contract accredited third-party laboratories to verify what we claim, and we provide those results with every order because your experimental integrity depends on it.

Researchers compare our standards across categories including immune peptides like Thymalin, nootropic compounds like Dihexa, and metabolic research tools like Tesofensine. The verification protocol remains identical: batch-specific HPLC purity analysis, mass spectrometry molecular weight confirmation, and bacterial endotoxin quantification below 5 EU/mg. If a peptide doesn't meet these standards, it doesn't ship. The 2–4% of batches we reject annually prove that quality control means rejecting product, not just testing it.

The information in this article is for research purposes only. Peptide sourcing, storage protocols, and experimental design decisions should align with institutional biosafety standards and applicable research guidelines. When choosing where to buy CJC-1295 no DAC online, prioritize suppliers who treat COA documentation as non-negotiable rather than those positioning it as a premium feature. Your data quality depends on it.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

CJC-1295 no DAC is the unmodified 29-amino-acid GHRH analog with a half-life of 20–30 minutes, producing pulsatile growth hormone release that mimics natural physiological patterns. CJC-1295 with DAC includes a Drug Affinity Complex modification (lysine linker plus maleimidoproprionic acid) that extends the half-life to 6–8 days by binding serum albumin, creating sustained non-pulsatile stimulation. The choice depends entirely on your research protocol — acute pulse studies require the no DAC form, while long-term steady-state investigations may use the DAC variant.

A legitimate COA must include the testing laboratory’s name and ISO 17025 accreditation number, the specific batch or lot number matching your vial label, the test date (preferably within 12 months), and detailed analytical data including HPLC chromatograms showing purity peaks and impurity profiles. Generic spec sheets listing only a purity percentage without chromatogram data or batch traceability are unverifiable. Always confirm the batch number on your vial matches the batch number on the COA before reconstituting the peptide.

Research-grade CJC-1295 no DAC should demonstrate ≥98% purity by HPLC analysis, verified through third-party laboratory testing. Purity below 98% indicates the presence of synthesis byproducts, truncated peptide sequences, or degradation products that can interfere with GHRH receptor binding and introduce variability in experimental results. Some suppliers advertise 95% purity as ‘research-grade,’ but this lower threshold is inadequate for controlled studies requiring reproducible dose-response relationships.

No — bacterial endotoxin contamination above 5 EU/mg can activate immune responses in cell culture and animal models, introducing confounding variables that invalidate experimental results. The LAL (Limulus Amebocyte Lysate) assay quantifies endotoxin levels, and research-grade peptides must remain below this threshold to ensure that observed effects result from GHRH receptor activation rather than innate immune signaling. Request a replacement batch if endotoxin levels exceed acceptable limits.

Store lyophilized CJC-1295 no DAC at −20°C in a sealed container with desiccant to prevent moisture absorption — peptides in powder form remain stable for 24–36 months under these conditions. Once reconstituted with bacteriostatic water, store the solution at 2–8°C (standard refrigeration) and use within 7–10 days. The unmodified peptide degrades more rapidly than DAC-modified variants due to enzymatic cleavage susceptibility, making longer storage post-reconstitution unreliable for maintaining peptide integrity.

Without batch-specific COA documentation, you cannot verify peptide purity, amino-acid sequence accuracy, molecular weight, or endotoxin contamination levels — meaning you have no analytical evidence that the compound matches the label claim. This introduces uncontrolled variables into your research protocol, making results unreproducible and potentially invalidating experimental data. Unverified peptides may contain the DAC-modified form mislabeled as ‘no DAC,’ degraded peptide fragments, or synthesis byproducts that alter pharmacokinetic behavior unpredictably.

The 20–30 minute half-life determines the temporal resolution of growth hormone receptor activation in your experimental model — this short duration allows researchers to study pulsatile signaling, circadian rhythm effects, and acute dose-response relationships that replicate physiological GHRH activity. Protocols examining sustained growth hormone elevation require the DAC-modified form, while studies investigating natural secretion patterns or synergistic effects with ghrelin receptor agonists demand the rapid clearance profile of the unmodified peptide.

Yes — CJC-1295 no DAC is frequently combined with GHRP-2, GHRP-6, or ipamorelin in research protocols because these compounds stimulate growth hormone release through complementary pathways (GHRH receptor vs ghrelin receptor). The synergistic effect produces greater growth hormone pulse amplitude than either compound alone, mimicking the hypothalamic-pituitary axis signaling that occurs during deep sleep or intense physical activity. Combination protocols require precise timing due to the no DAC form’s short half-life — typically administered within 15–30 minutes of each other.

Red flags include: no COA provided or only generic spec sheets available, batch numbers on vials not matching COA documentation, purity claims below 98%, missing HPLC chromatogram data, no third-party laboratory name or accreditation listed, peptides shipped without cold-chain packaging or temperature monitoring, and pricing significantly below market rates (suggesting low-purity or degraded inventory). Legitimate research-grade peptide suppliers maintain transparent quality documentation and cold-chain logistics as standard practice, not premium features.

When stored at −20°C in a sealed container with desiccant protection, lyophilized CJC-1295 no DAC maintains structural integrity and binding activity for 24–36 months post-synthesis. However, peptide stability begins declining after 12 months even under optimal storage due to gradual oxidation of methionine residues and deamidation of asparagine and glutamine — this degradation is slow but measurable via HPLC analysis. Purchase peptides synthesized within the past 12 months when possible, and verify the COA test date to confirm you’re not receiving old inventory.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA